Brief: Windtree Therapeutics Reports Second Quarter 2022 Financial Results And Provides Key Business Updates
11/08/2022 22:02
Aug 11 (Reuters) - Windtree Therapeutics Inc WINT.O :
* WINDTREE THERAPEUTICS REPORTS
SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES KEY BUSINESS UPDATES
* CASH AND CASH EQUIVALENTS AS OF JUNE 30 TO BE EXPECTED TO
BE
SUFFICIENT TO FUND OPERATIONS INTO Q1 OF 2023
* Q2 LOSS PER SHARE $0.59
Source text for Eikon: ID:nGNXGrDcz
Further company coverage: WINT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study